Kailera Therapeutics, Inc.
(KLRA - NASDAQ)
16,23 USD
📋 Profilo Aziendale

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.

|